The growing interest in successful weight management has led to considerable research into groundbreaking treatments. Lately , Retatrutide, a twin-action GIP and glucagon-like peptide-1 (GLP-1) receptor stimulator, has demonstrated promising results in clinical trials, indicating potential for substantial weight decrease. Therefore, several individ